Recollection of pain due to inappropriate versus appropriate implantable cardioverter-defibrillator shocks

PACE - Pacing and Clinical Electrophysiology

Volumn 34, Issue 3, 2011, Pages 348-353

  Marcus, Gregory M ^a   Chan, Derrick W ^a   Redberg, Rita F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

appropriate shock; ICD; implantable cardioverter defibrillator; inappropriate shock; pain

Indexed keywords

ADULT; ARTICLE; CARDIOVERSION; DEFIBRILLATOR; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PAIN; PAIN ASSESSMENT;

CALIFORNIA; COMORBIDITY; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC INJURIES; EQUIPMENT FAILURE; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PAIN; RISK ASSESSMENT; RISK FACTORS;

EID: 79952480037     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2010.02971.x     Document Type: Article

References (24)

1. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, et al,. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. New Engl J Med 2005; 352: 225-237. (Pubitemid 40110811)
2. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, 3rd, Freedman RA, Gettes LS, Gillinov AM, et al,. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008; 51: e1-e62. (Pubitemid 351689050)
3. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, et al,. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. New Engl J Med 2002; 346: 877-883. (Pubitemid 34984635)
4. Passman R, Subacius H, Ruo B, Schaechter A, Howard A, Sears SF, Kadish A,. Implantable cardioverter defibrillators and quality of life: Results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study. Arch Intern Med 2007; 167: 2226-2232. (Pubitemid 350106743)
5. Tung R, Zimetbaum P, Josephson ME,. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol 2008; 52: 1111-1121.
6. Kamphuis HC, de Leeuw JR, Derksen R, Hauer RN, Winnubst JA,. Implantable cardioverter defibrillator recipients: Quality of life in recipients with and without ICD shock delivery: A prospective study. Europace 2003; 5: 381-389. (Pubitemid 37336967)
7. Ladwig KH, Baumert J, Marten-Mittag B, Kolb C, Zrenner B, Schmitt C,. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: Results from the prospective living with an implanted cardioverter-defibrillator study. Arch Gen Psychiatry 2008; 65: 1324-1330.
8. Godemann F, Butter C, Lampe F, Linden M, Schlegl M, Schultheiss HP, Behrens S,. Panic disorders and agoraphobia: Side effects of treatment with an implantable cardioverter/defibrillator. Clin Cardiol 2004; 27: 321-326. (Pubitemid 38703084)
9. Van Den Broek KC, Nyklicek I, Van Der Voort PH, Alings M, Denollet J,. Shocks, personality, and anxiety in patients with an implantable defibrillator. Pacing Clin Electrophysiol 2008; 31: 850-857.
10. Pedersen SS, Theuns DA, Erdman RA, Jordaens L,. Clustering of device-related concerns and type D personality predicts increased distress in ICD patients independent of shocks. Pacing Clin Electrophysiol 2008; 31: 20-27.
11. Steinhaus DM, Cardinal DS, Mongeon L, Musley SK, Foley L, Corrigan S,. Internal defibrillation: Pain perception of low energy shocks. Pacing Clin Electrophysiol 2002; 25: 1090-1093. (Pubitemid 34828065)
12. Boriani G, Biffi M, Silvestri P, Martignani C, Valzania C, Diemberger I, Moulder C, et al,. Mechanisms of pain associated with internal defibrillation shocks: Results of a randomized study of shock waveform. Heart Rhythm 2005; 2: 708-713. (Pubitemid 40903676)
13. Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, et al,. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: Frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 2008; 51: 1357-1365. (Pubitemid 351443082)
14. Schron EB, Exner DV, Yao Q, Jenkins LS, Steinberg JS, Cook JR, Kutalek SP, et al,. Quality of life in the antiarrhythmics versus implantable defibrillators trial: Impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 2002; 105: 589-594. (Pubitemid 34123433)
15. Higgins SL, Lee RS, Kramer RL,. Stability: An ICD detection criterion for discriminating atrial fibrillation from ventricular tachycardia. J Cardiovasc Electrophysiol 1995; 6: 1081-1088. (Pubitemid 26025393)
16. Sweeney MO, Wathen MS, Volosin K, Abdalla I, DeGroot PJ, Otterness MF, Stark AJ,. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: Results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial. Circulation 2005; 111: 2898-2905. (Pubitemid 40814182)
17. Kuhlkamp V, Dornberger V, Mewis C, Suchalla R, Bosch RF, Seipel L,. Clinical experience with the new detection algorithms for atrial fibrillation of a defibrillator with dual chamber sensing and pacing. J Cardiovasc Electrophysiol 1999; 10: 905-915. (Pubitemid 29297709)
18. Swerdlow CD,. Supraventricular tachycardia-ventricular tachycardia discrimination algorithms in implantable cardioverter defibrillators: State-of-the-art review. J Cardiovasc Electrophysiol 2001; 12: 606-612. (Pubitemid 32452620)
19. Glikson M, Swerdlow CD, Gurevitz OT, Daoud E, Shivkumar K, Wilkoff B, Shipman T, et al,. Optimal combination of discriminators for differentiating ventricular from supraventricular tachycardia by dual-chamber defibrillators. J Cardiovasc Electrophysiol 2005; 16: 732-739. (Pubitemid 40994606)
20. Pacifico A, Hohnloser SH, Williams JH, Tao B, Saksena S, Henry PD, Prystowsky EN,. Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group. New Engl J Med 1999; 340: 1855-1862. (Pubitemid 29272665)
21. Alter P, Waldhans S, Plachta E, Moosdorf R, Grimm W,. Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients. Pacing Clin Electrophysiol 2005; 28: 926-932. (Pubitemid 43960867)
22. Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, Thorpe K, et al,. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: The OPTIC Study: A randomized trial. JAMA 2006; 295: 165-171. (Pubitemid 43076435)
23. Res JC, Theuns DA, Jordaens L,. The role of remote monitoring in the reduction of inappropriate implantable cardioverter defibrillator therapies. Clin Res Cardiol 2006; 95 (Suppl 3): III17-III21.
24. Schoenfeld MH, Compton SJ, Mead RH, Weiss DN, Sherfesee L, Englund J, Mongeon LR,. Remote monitoring of implantable cardioverter defibrillators: A prospective analysis. Pacing Clin Electrophysiol 2004; 27 (6 Pt 1): 757-763. (Pubitemid 38758757)